Results 1 to 10 of about 1,200,908 (357)

Permanent visual impairment following a Behçet's disease flare while on calcitonin gene-related peptide receptor antagonist therapy: a case report. [PDF]

BMC Ophthalmol
Khan FA, Malik A, Nelson E, Fahimdanesh K, Kaur K, Elison J, Sayed M.   +6 more
europepmc   +3 more sources

Peptide Receptor Radionuclide Therapy [PDF]

Best Practice & Research Clinical Gastroenterology, 2004
Abstract: On their plasma membranes, cells express receptor proteins with high affinity for regulatory peptides, such as somatostatin. Changes in the density of these receptors during disease, for example, overexpression in many tumors, provide the basis for new imaging methods.
Krenning, Eric, Kwekkeboom, Dik, Valkema, R., Pauwels, S, Kvols, LK, Jong, Marion   +5 more
openaire   +5 more sources

Probing Structure and Function of Alkali Sensor IRR with Monoclonal Antibodies

Biomolecules, 2020
To study the structure and function of the pH-regulated receptor tyrosine kinase insulin receptor-related receptor (IRR), а member of the insulin receptor family, we obtained six mouse monoclonal antibodies against the recombinant IRR ectodomain.
Alexander S. Goryashchenko, Andrey A. Mozhaev, Oxana V. Serova, Tatiana N. Erokhina, Alexander N. Orsa, Igor E. Deyev, Alexander G. Petrenko   +6 more
doaj   +1 more source

Lipidated Calcitonin Gene-Related Peptide (CGRP) Peptide Antagonists Retain CGRP Receptor Activity and Attenuate CGRP Action In Vivo

Frontiers in Pharmacology, 2022
Signaling through calcitonin gene-related peptide (CGRP) receptors is associated with pain, migraine, and energy expenditure. Small molecule and monoclonal antibody CGRP receptor antagonists that block endogenous CGRP action are in clinical use as anti ...
Aqfan Jamaluddin, Chia-Lin Chuang, Elyse T. Williams, Andrew Siow, Sung Hyun Yang, Paul W. R. Harris, Jakeb S. S. M. Petersen, Rebekah L. Bower, Shanan Chand, Margaret A. Brimble, Christopher S. Walker, Debbie L. Hay, Debbie L. Hay, Kerry M. Loomes   +13 more
doaj   +1 more source

Somatostatin receptor saturation after administration of high peptide amounts of [177Lu]Lu-HA-DOTATATE: when enough is enough

EJNMMI Research, 2022
Background Receptor saturation during peptide receptor radionuclide therapy (PRRT) could result in altered [177Lu]Lu-HA-DOTATATE uptake in tumors and organs.
Hinke Siebinga, Chayenne H. A. M. Veerman, Linda de Wit-van der Veen, Marcel P. M. Stokkel, Jeroen J. M. A. Hendrikx, Else A. Aalbersberg   +5 more
doaj   +1 more source

Peptide Receptor Radionuclide Therapy

The Journal of Clinical Endocrinology & Metabolism, 2022
Abstract The concept of using a targeting molecule labeled with a diagnostic radionuclide for using positron emission tomography or single photon emission computed tomography imaging with the potential to demonstrate that tumoricidal radiation can be delivered to tumoral sites by administration of the same or a similar targeting molecule
Johannes Hofland, Tessa Brabander, Frederik A Verburg, Richard A Feelders, Wouter W de Herder   +4 more
openaire   +3 more sources

Formyl Peptide Receptor as a Novel Therapeutic Target for Anxiety-Related Disorders [PDF]

, 2014
Formyl peptide receptors (FPR) belong to a family of sensors of the immune system that detect microbe-associated molecules and inform various cellular and sensorial mechanisms to the presence of pathogens in the host.
A Alam, A Strohle, AC Carpenter, AK Sato, AL Stenfeldt, BA Babbin, C Gemperle, C Marquez, C Touma, CA Janeway Jr, CC Wentworth, CC Wentworth, CK Derian, D El Kebir, D Yang, D Yang, DA Christakis, DE Ganella, E Krump, Elisabetta Panza, F Cattaneo, F Miceli, F Sallusto, FA Costa-Pinto, FN Gavins, FN Gavins, Fulvio D'Acquisto, G De Palma, G Taglialatela, Giuseppa Piras, GT Condo, H Lim, H Mou, IA Olsson, IJ Santos-Soto, Irene Gallo, JA Foster, Jeffrey W. Dalley, JF Cryan, JF Cryan, JL Barr, JL Gao, JL Leasure, JP Onnela, JW Jahng, K Chen, K Chen, KL McIlwain, KM Neufeld, L Spurr, LM Sutton, Lorenza Rattazzi, M Antunes, M Aoki, M Bourin, M Bourin, M Keitoku, M Perretti, M Saigo, MA Panaro, Mauro Perretti, MG Gareau, MJ Molloy, MJ Rane, MM van Gaalen, N Benaroya-Milshtein, N Dufton, N Dufton, P Anton, Q Wang, Q Zhang, R Diaz Heijtz, R Luisi, R Medzhitov, RD Ye, RM Deacon, RM Deacon, RM Deacon, RN Walsh, RS Kasai, S Fediuc, S Ihara, S Kedia, S Park, S Pellow, S Riviere, SB Su, SC Heo, SD Liberles, SD Munger, SN Cooray, T Sato, Thomas Gobbetti, Tiziana Rubino, TJ Schoenfeld, V Marashi, Y De, YH Cui, YH Cui   +98 more
core   +11 more sources

New Frontiers in Molecular Imaging Using Peptide-Based Radiopharmaceuticals for Prostate Cancer

Frontiers in Chemistry, 2020
The high incidence of prostate cancer (PCa) increases the need for progress in its diagnosis, staging, and precise treatment. The overexpression of tumor-specific receptors for peptides in human cancer cells, such as gastrin-releasing peptide receptor ...
Xin Li, Huawei Cai, Xiaoai Wu, Li Li, Haoxing Wu, Rong Tian   +5 more
doaj   +1 more source

PaFlexPepDock: parallel ab-initio docking of peptides onto their receptors with full flexibility based on Rosetta. [PDF]

PLoS ONE, 2014
Structural information related to protein-peptide complexes can be very useful for novel drug discovery and design. The computational docking of protein and peptide can supplement the structural information available on protein-peptide interactions ...
Haiou Li, Liyao Lu, Rong Chen, Lijun Quan, Xiaoyan Xia, Qiang Lü   +5 more
doaj   +1 more source

Glucagon-Like Peptide-1 Receptor Agonists for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: A Meta-Analysis

Frontiers in Endocrinology, 2021
ObjectiveNon-alcoholic fatty liver disease is highly prevalent in patients with type 2 diabetes mellitus. Studies on glucagon-like peptide-1 receptor agonists for the treatment of non-alcoholic fatty liver disease have reported promising results. Despite
Chloe Wong, Ming Hui Lee, Clyve Yu Leon Yaow, Yip Han Chin, Xin Lei Goh, Cheng Han Ng, Amanda Yuan Ling Lim, Amanda Yuan Ling Lim, Mark Dhinesh Muthiah, Mark Dhinesh Muthiah, Mark Dhinesh Muthiah, Chin Meng Khoo, Chin Meng Khoo   +12 more
doaj   +1 more source